CYP2B6 and amyotrophic lateral sclerosis: The TSR is due to a known resistance-conferring ALS mutation of Pro-197-Thr and the NTSR is likely due to P450-mediated metabolic resistance and ABC transporter- mediated sequestration of the metabolites.